EcoDrugPlus

Casein Kinase 1, Epsilon

Ensembl ID : ENSACIG00000022041
Gene Symbol: CSNK1E
1 Cross references
205 Possible Orthologues:

Caspase 9, Apoptosis-Related Cysteine Peptidase

Ensembl ID : ENSACIG00000015806
Gene Symbol: CASP9
1 Cross references
204 Possible Orthologues:

Catechol-O-Methyltransferase B

Ensembl ID : ENSACIG00000010204
Gene Symbol: COMTB
1 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSACIG00000023272
Gene Symbol: CTSC
1 Cross references
239 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSACIG00000005713
Gene Symbol: CTSK
1 Cross references
226 Possible Orthologues:

Cathepsin S, Ortholog2, Tandem Duplicate 1

Ensembl ID : ENSACIG00000004716
Gene Symbol: CTSS2.1
1 Cross references
235 Possible Orthologues:

Cell Division Cycle 7 Homolog (S. Cerevisiae)

Ensembl ID : ENSACIG00000021505
Gene Symbol: CDC7
1 Cross references
209 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSACIG00000003339
Gene Symbol: CHEK1
1 Cross references
179 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSACIG00000002245
Gene Symbol: CHEK2
1 Cross references
206 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9a

Ensembl ID : ENSACIG00000003541
Gene Symbol: CCR9A
1 Cross references
190 Possible Orthologues:

Chemokine (C-X-C Motif) Receptor 4a

Ensembl ID : ENSACIG00000015281
Gene Symbol: CXCR4A
1 Cross references
216 Possible Orthologues:

Cholecystokinin B Receptor A

Ensembl ID : ENSACIG00000018209
Gene Symbol: CCKBRA
1 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).